Question 1

What is Ofatumumab used for?

Accepted Answer

Ofatumumab (brand name Kesimpta) is a Anti-CD20 Monoclonal Antibody indicated for Relapsing Multiple Sclerosis.

Question 2

How does Ofatumumab work?

Accepted Answer

Ofatumumab works through the following mechanism: Fully human anti-CD20 monoclonal antibody self-administered subcutaneously that depletes B cells..

Question 3

What are the most common side effects of Ofatumumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Ofatumumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Ofatumumab the same as Kesimpta?

Accepted Answer

Kesimpta is a brand name for Ofatumumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Ofatumumab

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations